The exploratory study to evaluate the association between efficacy of bevacizumab combination therapy and pretreatment plasma vascular endothelial growth factor-D levels in metastatic colorectal cancer (GI-SCREEN-CRC-Ukit additional study 01)

ABSTRACT: Primary outcome(s): To evaluate the association between plasma VEGF-D levels and the efficacy of bevacizumab combination therapy in patients with colorectal cancer.

DISEASE(S): Colorectal Cancer

PROVIDER: 2660056 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR